Artwork
iconShare
 
Manage episode 515273925 series 3647435
Content provided by Rachel (@bottomlineibd) and Nigel (@crohnoid), Rachel (@bottomlineibd), and Nigel (@crohnoid). All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Rachel (@bottomlineibd) and Nigel (@crohnoid), Rachel (@bottomlineibd), and Nigel (@crohnoid) or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Meet Olie Bosley.

Olie is an IT and cybersecurity expert from Oxford, UK who has suffered from Crohn's disease symptoms for nearly 30 years.

We invited Olie to join us for this episode as he has an important story to share: what happens when the drug that has kept you well for so long - in his case Humira (adalimumab) - without notice causes you side effects that mean you need to stop taking it.

Olie speaks with candour to Nigel and me on the practical and psychological challenges this brings a patient who hitherto had well controlled inflammatory bowel disease. His story is a testament to resilience, advocating for oneself and the importance on inter-department communication when treating IBD patients.

🔍 What You’ll Learn

  • How a childhood injury may have shaped Olie’s health trajectory
  • The possible link between seronegative arthritis and Crohn’s disease
  • Why Olie delayed his first colonoscopy... and what changed his mind
  • The impact of NSAIDs on gut health and Crohn’s progression
  • Olie’s experience with methotrexate, azathioprine, Humira, infliximab, ustekinumab and Rinvoq
  • The overlooked reality of bile acid malabsorption after TI surgery
  • How UVB therapy helped resolve a Humira-related skin reaction
  • The importance of communication between rheumatology, dermatology and IBD teams

You can follow Olie Bosley on X (@Olski).

Follow Rachel at @bottomlineibd

Follow Nigel at @crohnoid

  continue reading

21 episodes